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The present study was undertaken in order to understand more about the interaction
occurring between S. maltophilia and P. aeruginosa, which are frequently co-isolated
from CF airways. For this purpose, S. maltophilia RR7 and P. aeruginosa RR8 strains,
co-isolated from the lung of a chronically infected CF patient during a pulmonary
exacerbation episode, were evaluated for reciprocal effect during planktonic growth,
adhesion and biofilm formation onto both polystyrene and CF bronchial cell monolayer,
motility, as well as for gene expression in mixed biofilms. P. aeruginosa significantly
affected S. maltophilia growth in both planktonic and biofilm cultures, due to an
inhibitory activity probably requiring direct contact. Conversely, no effect was observed
on P. aeruginosa by S. maltophilia. Compared with monocultures, the adhesiveness of
P. aeruginosa on CFBE41o- cells was significantly reduced by S. maltophilia, which
probably acts by reducing P. aeruginosa’s swimming motility. An opposite trend was
observed for biofilm formation, confirming the findings obtained using polystyrene. When
grown in mixed biofilm with S. maltophilia, P. aeruginosa significantly over-expressed
aprA, and algD—codifying for protease and alginate, respectively—while the quorum
sensing related rhlR and lasI genes were down-regulated. The induced alginate
expression by P. aeruginosa might be responsible for the protection of S. maltophilia
against tobramycin activity we observed in mixed biofilms. Taken together, our results
suggest that the existence of reciprocal interference of S. maltophilia and P. aeruginosa
in CF lung is plausible. In particular, S. maltophilia might confer some selective
“fitness advantage” to P. aeruginosa under the specific conditions of chronic infection
or, alternatively, increase the virulence of P. aeruginosa thus leading to pulmonary
exacerbation.
Keywords: cystic fibrosis, lung infections, Stenotrophomonas maltophilia, Pseudomonas aeruginosa, microbial
interactions
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Introduction
Pulmonary disease is the leading cause of morbidity and
mortality in cystic fibrosis (CF) patients, in whom defective
mucociliary clearance and impaired innate immunity lead to
chronic pulmonary infections (Lyczak et al., 2002). During CF
airway disease periods of stability are punctuated by acute
pulmonary exacerbations (PEs) in which overt immunological
responses are the main causes of irreversible lung damage
(Amadori et al., 2009; Sanders et al., 2011). Recurrent PEs
are associated with a shortened survival (Emerson et al., 2002;
Marshall, 2004).
The pathophysiology of PEs is not yet completely understood.
Aside from acute viral infections which, especially in children,
have been associated with up to one-third of PEs (Armstrong
et al., 1998; Clifton et al., 2008), Pseudomonas aeruginosa has
been considered the primary cause of PEs and related long-term
decline in lung function (Goss and Burns, 2007; Sanders et al.,
2010).
The pathogenesis of P. aeruginosa infection depends
on several cell-associated and extracellular virulence
factors, including proteases and toxins, whose expression is
mainly regulated by hierarchically organized inter-bacterial
communication LasRI and RhIRI quorum sensing (QS) systems,
which monitor population size using various diffusible N-
acylhomoserine lactones as signal molecules (Goodman and
Lory, 2004).
However, this view is not convincingly supported by either the
clinical or the microbiological evidence available.
Several studies have reported that in adult CF patients the
anti-pseudomonal antibiotic therapy frequently did not reduce
P. aeruginosa load and airways inflammation (Wolter et al., 1999;
Reid et al., 2004), and that about 25% of patients experiencing a
PE did not recover their baseline lung function after treatment,
leading to a progressive deterioration in their clinical status
over time (Sanders et al., 2010, 2011). Furthermore, in other
studies no increase in P. aeruginosa concentration was observed
immediately prior to, or at the time of, PE (Stressmann et al.,
2011; Reid et al., 2013). Recent epidemiological data indicate that
coinfections involving different species of bacteria are common,
and probably represent the norm, in CF lung (Harrison, 2007;
Bittar et al., 2008; Sibley et al., 2008a; Rogers et al., 2010a).
P. aeruginosa is the most common species found in CF airways,
but other species are frequently co-isolated in CF lung (Harrison,
2007).
The pathophysiology of PEs in CF could be, therefore, directly
related to changes in microbial behavior and/or to the dynamics
of the interactions between the constituents of the complex
microbial communities present. Several studies have recently
highlighted the potential role of interspecies interactions in
influencing infection status, clinical outcomes or response to
Abbreviations: CF, cystic fibrosis; PE, pulmonary exacerbation; QS, quorum
sensing; MHA, Mueller-Hinton agar; TSB, tryptone soya broth; CAMHB, cation-
adjusted Mueller-Hinton broth; PBS, phosphate buffered saline; OD, optical
density; EDTA, ethylenediaminetetraacetic acid; MOI, multiplicity of infection;
RT-PCR, real-time PCR; CI, competitive index; RIR, relative increase ratio; EPS,
extracellular polymeric substance.
therapy in CF patients (Harrison, 2007; Ryan et al., 2008; Sibley
et al., 2008b, 2009; Shank and Kolter, 2009; Rogers et al., 2010b).
Taken together, these findings suggest that the role of microbial
species other than P. aeruginosa needs to be considered.
Stenotrophomonas maltophilia is one of the most common
emerging multi-drug resistant organisms found in the lungs of
people with CF where its prevalence is increasing (Ciofu et al.,
2013). Nevertheless, the role of S. maltophilia in the pathogenesis
of CF lung disease is not yet clear because of conflicting results
from clinical studies which focused on the correlation between
the presence of this microorganism and lung damage (Karpati
et al., 1994; Goss et al., 2002). In a series of studies, we found
evidence highly suggestive of the pathogenic role of S. maltophilia
in CF patients (Di Bonaventura et al., 2004, 2007a,b, 2010;
Pompilio et al., 2008, 2010, 2011). This microorganism can
grow as biofilms—sessile communities inherently resistant to
antibiotics and host immune response—not only on abiotic
surfaces (Di Bonaventura et al., 2004, 2007a,b; Pompilio et al.,
2008), but also on CF-derived epithelial monolayer (Pompilio
et al., 2010), probably because of a selective adaptation to CF
airways (Pompilio et al., 2011). Furthermore, in a murine model
of acute respiratory infection we observed that S. maltophilia
significantly contributes to the inflammatory process resulting
in compromised respiratory function and death (Di Bonaventura
et al., 2010).
S. maltophilia is often co-isolated with P. aeruginosa, with
a frequency ranging from 10 to 60% of CF patients (Spicuzza
et al., 2009; Blau et al., 2014; Zemanick et al., 2015); however,
no data are available on this at the onset of PE. It is, therefore,
plausible to hypothesize that these species interact and that
this could potentially affect the virulence and persistence of
P. aeruginosa. While several studies have focused on the
interaction of P. aeruginosa with other bacterial species (Qin
et al., 2009; Pihl et al., 2010; Baldan et al., 2014), very little
has been published on the interaction between P. aeruginosa
and S. maltophilia. In this regard, Ryan et al. (2008) found that
the presence of S. maltophilia increases P. aeruginosa resistance
to polymyxin by a diffusible signal factor, while Kataoka et al.
(2003) observed that β-lactamases leaking from S. maltophilia
can encourage the growth of P. aeruginosa in the presence of
imipenem or ceftazidime.
Recently, we observed that the pre-incubation of the CF
bronchial epithelial IB3-1 cells with S. maltophilia decreases
the adherence of P. aeruginosa, while previous P. aeruginosa
infection may increase the likelihood of S. maltophilia colonizing
a damaged CF pulmonary mucosa (Pompilio et al., 2010).
Our hypothesis, based on these clinical and experimental
findings, was that in CF lung S. maltophilia may indirectly
contribute to disease development by providing a favorable
growth environment for P. aeruginosa and/or by modulating
some virulence traits exhibited by P. aeruginosa. In order to
test this hypothesis, S. maltophilia RR7 and P. aeruginosa RR8—
two strains co-isolated at the same time from the lung of a CF
patient during a PE episode—were evaluated, both in combined
and monomicrobial cultures, with respect to planktonic growth,
adhesion and biofilm formation onto both polystyrene and
CF bronchial cell monolayer, and motility. The effect of
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S. maltophilia RR7 on the expression of selected P. aeruginosa
RR8 virulence genes was also assessed in mixed biofilms.
We show that S. maltophilia has the potential to significantly
affect P. aeruginosa virulence, which suggests that interspecies
interactions are operative in promoting bacterial pathogenicity
in CF lung infections.
Materials and Methods
Bacterial Strains and Growth Conditions
P. aeruginosa RR8 and S. maltophilia RR7 strains were co-
isolated from the same sputum sample collected, during a PE,
from a 15-year-old CF patient (named “RR”) attending Children
Hospital "Bambino Gesù" of Rome. The patient was selected
because he was chronically infected by both P. aeruginosa and
S. maltophilia, according to the definition proposed by the
EuroCareCF Working Group (Pressler et al., 2011). The strains
were identified by the API 20-NE system (bioMérieux, Marcy-
L’Etoile, France) and stored at −80◦C until use. Fresh bacterial
stocks were thawed and grown twice on Mueller-Hinton agar
(MHA; Oxoid S.p.A., Garbagnate M.se, Italy) to check for purity
and to regain the original phenotype: (i) P. aeruginosa RR8 strain
was mucoid and resistant to amikacin and gentamicin only;
(ii) S. maltophilia RR7 strain, not mucoid, showed resistance
to ceftazidime, piperacillin/tazobactam, amikacin, gentamicin,
ciprofloxacin, and levofloxacin.
All assays were carried out by using a standardized bacterial
inoculum. Briefly, an overnight culture in tryptone soya broth
(TSB), grew under agitation (130 rpm) at 37◦C, was adjusted with
sterile broth to an OD550 corresponding to 1–3×10
8 CFU/ml for
both strains, then diluted 1:10 in cation-adjustedMueller-Hinton
broth (CAMHB; Becton, Dickinson and Company; Milan, Italy)
(pH 7.2–7.4).
Mono- and Co-culture Planktonic Growth
Each well of a 96-well polystyrene, flat bottom, tissue culture-
treated microtiter (BD Falcon, Milan, Italy) was seeded with
100µl of each standardized inoculum (dual cultures) or 100µl of
standardized inoculum+100µl sterile medium (single cultures).
Microtiters were then statically incubated at 37◦C, under
aerobic atmosphere, for 24 h. At different time points (2, 4,
6, 8, 10, and 24 h) samples were taken, serially diluted in
sterile phosphate buffered saline (PBS; Sigma-Aldrich S.p.A.;
Milan, Italy) (pH 7.2), then plated onto MHA + imipenem at
32µg/ml or Pseudomonas cetrimide agar (Oxoid) to discriminate
S. maltophilia, and P. aeruginosa growth, respectively. The agar
plates were incubated at 37◦C for 24 h when the CFU number
was recorded.
Kinetics of Adhesion and Biofilm Formation by
Single and Mixed Cultures
Each well of a 96-well polystyrene, flat bottom, tissue culture-
treated microtiter was seeded as described above, and statically
incubated at 37◦C, under aerobic atmosphere, for 3 h (adhesion)
or up to 7 days (biofilm formation). During biofilm formation
assay, CAMHBwas replaced daily with fresh broth. At each time-
point considered (3 h, and 1–7 days), samples were washed twice
with sterile PBS, and then adhesion or biofilm were measured
for both biomass and viability. Biomass was measured in terms
of optical density read at 492 nm (OD492) following crystal
violet staining, as previously described (Pompilio et al., 2008),
considering a low cut-off of ODc + 3 × SDs, where ODc
is OD492 of control wells (containing medium alone without
bacteria). For viability assessment, samples were exposed to
trypsin-ethylenediaminetetraacetic acid (EDTA) 0.25% (Sigma-
Aldrich) to allow detachment from the polystyrene, and then the
viable count was carried out as described above.
Preparation of Cell-free Culture Supernatant
For each strain, some colonies from an overnight MHA growth
were suspended in 20ml of TSB and incubated overnight at
37◦C, under agitation (220 rpm). Supernatants were obtained
after centrifugation at 12,000 × g, for 10min at 4◦C, followed
by sterile filtration using a 0.20µm-pore-size filter (Corning;
Tewksbury, MA, USA), and storage at−80◦C until use.
Evaluation of Antibacterial Activity by
S. maltophilia RR7 and P. aeruginosa RR8
The antibacterial activity of each strain was evaluated by the
drop test assay. Briefly, 100µl of the standardized inoculum
containing the indicator strain were streaked onto an MHA
surface using a cotton swab, and then the plate was dried at 30◦C
for 30min. The test strain was then evaluated for antimicrobial
activity, both as cell suspension and supernatant. Drops
containing 10µl of the supernatant or standardized suspension,
and a control, were placed on the agar surface and the inhibition
zone diameter was measured after incubation at 37◦C for 24 h.
To evaluate whether the inhibitory activity of P. aeruginosa
RR8 on S. maltophilia RR7 required direct cell-cell interactions,
a transwell-based assay was performed. Briefly, P. aeruginosa
RR8 was inoculated at 1–5 × 108 CFU/ml in the upper insert
(Cell Culture Insert; BD Falcon), while S. maltophilia RR7 was
inoculated at the same concentration in the bottom of the culture
well. Following 24 h-incubation at 37◦C, suspensions from both
compartments underwent a viable count. A sample where the
upper insert contained TSB without P. aeruginosa RR8 was used
as control.
Adhesion to, and Biofilm Formation on CF
Bronchial Cells
CFBE41o- bronchial cells, derived from a CF patient
homozygous for the F508del CFTR mutation, were obtained
from Dr. Dieter C. Gruenert (University of California, San
Francisco, USA). Briefly, confluent CFBEo- cells were grown
in tissue polystyrene culture flasks (BD Falcon) in Minimum
Essential Medium (GIBCO, Life-technologies; Monza, Italy)
supplemented with 10% fetal bovine serum (GIBCO), 50
U/ml penicillin, 50µg/ml streptomycin (both from Sigma-
Aldrich), and 2mM L-glutamine (GIBCO). Monolayers
were simultaneously infected with S. maltophilia RR7 and
P. aeruginosa RR8 strains (ratio 1:1, each at 106 CFU/ml;
multiplicity of infection, MOI: 10), then incubated at 37◦C for
3 h (adhesion assay) or 24 h (biofilm formation assay). CFBE41o-
cell monolayers infected with a single strain (at 106 CFU/ml)
were prepared as control. At the end of incubation, infected
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monolayers were washed twice with PBS, then detached by 0.25%
trypsin/EDTA, and finally plated for colony count.
Tobramycin Activity against Planktonic and
Biofilm Cells
MICs of tobramycin (Sigma-Aldrich) for S. maltophilia RR7 and
P. aeruginosa RR8 were respectively 128 and 4µg/ml, as assessed
by microdilution technique in accordance with the M100-S20
protocol [Clinical and Laboratory Standards Institute, 2010].
Tobramycin was also tested against preformed single species and
mixed biofilms. Briefly, biofilms were allowed to form at 37◦C for
24 h as described in “Kinetics of adhesion and biofilm formation
by single and mixed cultures.” Samples were washed once with
sterile CAMHB, and then exposed to 200µl of tobramycin at
128µg/ml. After incubation at 37◦C for 24 h, non-adherent
bacteria were removed by washing twice with sterile PBS, and
biofilm cells were scraped with a pipette tip following 5min-
exposure to 100µl trypsin-EDTA 0.25%. Cell suspension was
vortexed at high speed for 1min to break up the clumps, and
then bacterial counts were assessed by plating serial 10-fold
dilutions of the biofilm cell suspension onto selective media
MHA plates.
Motility Assays
Swimming, swarming, and twitching motilities were evaluated
using dedicated agar media, as previously described (Pompilio
et al., 2008). The relative motility of two strains was assessed
by using agar prepared with and without 1:2 diluted culture
supernatant of the other strain.
Gene Expression Assay in Mixed Biofilm
The effect of S. maltophilia RR7 on the transcription levels
of several virulence factors (Table 1) of P. aeruginosa RR8
was assessed in mixed biofilms by real-time PCR (RT-PCR).
P. aeruginosa RR8 was cultured as biofilm, both alone and with
S. maltophilia RR7, in 24-well polystyrene, flat bottom, tissue
culture-treated microtiter (BD Falcon), as described above.
Following 24 h-incubation at 37◦C, biofilms were washed, and
then harvested by scraping in Qiazol (Qiagen; Milan, Italy).
RNA was then extracted by the phenol-chloroform technique
(Kang et al., 2009), treated with DNase I (Applied Biosystems
Italia; Monza, Italy), and checked for purity by NanoDrop-2000
spectrophotometer (Thermo Scientific Italia; Milan, Italy). First
strand cDNA was synthesized using a High Capacity cDNA
reverse transcription kit (Applied Biosystems) according to the
manufacturer’s protocol. Gene expression was evaluated using a
SYBR green (Applied Biosystems) RT-PCR assay. The primers’
specificity was assessed both in silico with BLAST and by PCR
endpoint under the same RT-PCR conditions. Each amplification
assay was also tested for S. maltophilia RR7 as an additional
negative control in each RT-PCR. The11Ct method was used to
determine the relative gene expression of each gene in co-culture
vs. monoculture biofilms normalized to the expression of the
housekeeping gene proC.
Interpretative Criteria and Statistical Analysis
Each experiment was performed in triplicate and repeated on
two different occasions. All statistical analyses were performed
by GraphPad Prism software (ver. 4.0; GraphPad Inc, San
TABLE 1 | List of primer sequences used in RT-PCR for expression analysis of virulence genes by P. aeruginosa RR8 grown as biofilm, both in solo and
co-cultured with S. maltophilia RR7.
Primers, 5′–3′ Primer ID Target gene Gene function References
CTCAGGATGATGGCGATTTC rhlR-F rhlR Quorum sensing Pérez-Osorio et al., 2010
AATTTGCTCAGCGTGCTTTC rhlR-R – – –
GCGTGCTGCACTACTCCATG toxA-F toxA Exotoxin A Davinic et al., 2009
GTTACCGGCGTTCAGTTCGT toxA-R – – –
GCTGCGAAACGCTGTTCTTC vfr-F vfr Virulence regulator las system Davinic et al., 2009
GCTGCCGAGGGTGTAGAGG vfr-R – – –
GCGACCTGGACCTGGGCT algD-F algD Enhancer for alginate synthesis Joly et al., 2005
TCCTCGATCAGCGGGATC algD-R – – –
GCTTCTGCACGGCAAGGA lasI-F lasI Quorum sensing Joly et al., 2005
ATGGCGAAACGGCTGAGTT lasI-R – – –
GGCGGATGCGGAAAAGTAC exoS-F exoS Type III system effector Joly et al., 2005
CTGACGCAGAGCGCGATT exoS-R – – –
TACTCGCTGGGCAAGTTCAGGCG aprA-F aprA Alkaline protease Vettoretti et al., 2009
GTAGCTCATCACCGAATAGGCG aprA-R – – –
GTACCGGCGTCATGC AGGGTTC mexC-F mexC Efflux pump Savli et al., 2003
TTACTGTTGCGGCGCAGGTGACT mexC-R – – –
CCAGGACCAGCACGAACT TCT TGC mexE-F mexE Efflux pump Vettoretti et al., 2009
CGACAACGCCAAGGGCGAGTTCACC mexE-R – – –
CAGGCCGGGCAGTTGCTGTC proC-F proC* Proline biosynthesis Savli et al., 2003
GGTCAGGCGCGAGGCTGTCT proC-R – – –
*proC was tested as housekeeping gene.
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Diego, USA), considering as statistically significant a p-
value less than 0.05. Differences were assessed by ANOVA-
test followed by Newman-Keuls multiple comparison post-
test (kinetics of planktonic growth, adhesion and biofilm
formation onto both polystyrene and CFBE41o- cells, and
tobramycin activity against preformed biofilms), chi-square
test (adhesion and biofilm formation efficiency) or paired
Student’s t-test (motility and gene expression). The efficiency
of adhesion and biofilm formation onto CFBE41o- cells
was calculated for each strain, both in single and mixed
infections, as a percentage referred to the initial inoculum:
(A/B) × 100, where A is the number of adhered or biofilm
bacteria, and B is the number of bacteria in the initial
inoculum.
In mixed cultures, the Competitive Index (CI) was defined
as the S. maltophilia/P. aeruginosa ratio within the output
sample divided by the corresponding ratio in the inoculum
(input): CI= (S. maltophilia/P. aeruginosa)output/(S. maltophilia/
P. aeruginosa)input, where output and input samples were
assessed after plating onto MHA serial dilutions of the sample
taken at fixed times or the inoculum (t = 0), respectively (Macho
et al., 2007). For statistical analyses, CI values were first subjected
to a Log transformation for normal distribution, then interpreted
as follows: a CI value equal to 0 indicates equal competition of the
two species; a positive CI value indicates a competitive advantage
for S. maltophilia; a negative CI value indicates a competitive
advantage for P. aeruginosa.
Similarly to CI, the Relative Increase Ratio (RIR) was
calculated based on the growth results obtained from
monocultures of each strain (Macho et al., 2007). Each CI
and RIR was analyzed using the Student’s t-test and the null
hypothesis: the mean index was not significantly different from
1.0. When appropriate, CI and RIR from a given experiment
were compared using unpaired Student’s t-test, and significant
differences are suggestive of a meaningful competition between
the species (Macho et al., 2007).
Results
P. aeruginosa Significantly Affects S. maltophilia
Growth in Planktonic Culture
The growth curve kinetics of P. aeruginosa RR8 and
S. maltophilia RR7 strains, tested as alone or in mixed
culture, were assessed by colony count over 24 h, and the
results are shown in Figure 1A. When grown in mixed cultures,
the growth kinetics of the two strains were comparable.
However, compared with single cultures, the growth of
both S. maltophilia RR7 and P. aeruginosa RR8 in mixed
cultures was negatively affected during both log and stationary
phases.
To assess further the meaning of the differences between the
variations observed in single vs. mixed cultures, CI and RIR
were calculated and compared, as shown in Figure 1B. The CI
of S. maltophilia RR7 vs. P. aeruginosa RR8 was significantly
different from the respective RIR values between 6 h- and
24 h-incubation, suggesting that P. aeruginosa RR8 exerts an
inhibitory effect on S. maltophilia RR8 growth during both log
and stationary growth phases.
P. aeruginosa Exhibits Antimicrobial Activity
against S. maltophilia in a Contact-dependent
Manner
The agar spot assay results showed that P. aeruginosa RR8 is
active against S. maltophilia RR7, although only when tested
as cell suspension (diameter of inhibition zone, mean ± SD:
12.5 ± 1.4mm), and not as supernatant (Figure 1C). However,
the inhibition halo showed a partial regrowth, suggesting that
a partial inhibition occurred. Conversely, S. maltophilia RR7
showed no activity against P. aeruginosa RR8, as supernatant or
suspension (Figure 1C).
The inhibitory effect of P. aeruginosa RR8 on S. maltophilia
RR7 was also assessed using a transwell-based assay, and the
results are shown in Figure 1D. S. maltophilia growth was not
significantly affected by the presence of P. aeruginosa (9.6 ±
3.4 × 108 CFU/ml vs. 5.9 ± 3.9 × 108 CFU/ml for unexposed
and exposed S. maltophilia, respectively; p > 0.05), which
suggests that P. aeruginosa inhibits S. maltophilia growth in a
contact-dependent manner.
Kinetics of S. maltophilia and P. aeruginosa
Interaction during Adhesion and Biofilm
Formation onto Polystyrene
The interaction during adhesion phase between S. maltophilia
RR7 and P. aeruginosa RR8 strains was assessed, tested as single
and mixed cultures, after 3 h-incubation, both by crystal violet
and the viable count assays; the results are reported in Figure 2.
The crystal violet assay showed that P. aeruginosa RR8, when
cultured alone, exhibited a significantly higher adhesiveness than
S. maltophiliaRR7 (OD492, mean± SD: 0.781± 0.095 vs. 0.079±
0.026, respectively; p < 0.001) (Figure 2A). No differences,
however, were found between the strains in terms of cell
viability (Figure 2B), which suggests that extracellular polymeric
substance (EPS) contributes substantially to P. aeruginosa RR8
adhesion.
In mixed infections, the numbers of viable cells of each strain
that adhered to polystyrene were not affected by the presence of
the other (Figure 2B), as was confirmed by comparable CI and
RIR values (Figure 2C). However, in mixed culture the biomass
adhesion level of S. maltophilia RR7 was significantly lower than
that of P. aeruginosa RR8 (OD492, mean ± SD: 0.645 ± 0.051
vs. 0.781 ± 0.095, respectively; p < 0.01), which indicates
that the presence of S. maltophilia RR7 leads to a reduction in
P. aeruginosa RR8 EPS.
The interaction in biofilm growth between S. maltophilia RR7
and P. aeruginosa RR8, tested as single and mixed cultures, was
monitored over 7 days, by both crystal violet and viable count
assays; results are shown in Figure 3.
The kinetics of biofilm formation, as assessed by crystal
violet staining, are summarized in Figure 3A. In monoculture,
from day 1 until day 5 of incubation P. aeruginosa RR8
formed significantly higher biofilm biomass amount than
S. maltophilia RR7. The kinetics of biofilm formation
by P. aeruginosa RR8 and RR7+RR8 mixed infection
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FIGURE 1 | Kinetics of planktonic growth exhibited by S. maltophilia RR7 and P. aeruginosa RR8, considered both as alone and in combination.
S. maltophilia RR7 and P. aeruginosa RR8 were grown for 24 h in CAMHB in single culture and in co-culture after inoculation at equal ratio from mid-exponential phase
pure cultures. Growth rate was monitored by colony count after plating on selective media for both species. (A) Growth curves of S. maltophilia RR7 and
P. aeruginosa RR8 strains in pure culture (RR7, RR8) and in co-culture (RR7combi, RR8combi). The results are shown as mean + SD (n = 6). *p < 0.05, **p < 0.01,
RR7 vs. RR8; §p < 0.05, RR8 vs. RR8combi; ∧p < 0.05, ∧∧p < 0.01, RR7 vs. RR7combi; ANOVA + Newman-Keuls post-test. (B) Competitive index (CI; black bars)
and Relative Increase Ratio (RIR; gray bars) calculated from single and dual planktonic cultures of S. maltophilia RR7 and P. aeruginosa RR8 strains. The results are
shown as mean ± SD (n = 6). *p < 0.05, **p < 0.01, CI vs. RIR, unpaired t-test. (C) Evaluation of antibacterial activity using agar spot assay. S. maltophilia RR7 vs.
P. aeruginosa RR8 (left): no antibacterial activity. P. aeruginosa RR8 vs. S. maltophilia RR7 (right): partial antibacterial activity, as suggested by the regrowth observed
within the inhibition zone. (D) Transwell assay: S. maltophilia RR7 growth without or with (exp) P. aeruginosa RR8. The results are expressed as mean + SD (n = 6).
followed a comparable trend throughout the 7 day period.
From day 2 until day 5 of incubation, the mean biofilm
biomass amount formed by both P. aeruginosa RR8
and mixed infection was significantly higher than when
S. maltophilia RR7 was cultured alone. On day 6, all
conditions tested produced comparable mean biofilm biomass
values.
The biofilm formation kinetics evaluated by the viable count
are shown in Figure 3B. In monoculture, the viability of
biofilm formed by S. maltophilia RR7 was higher than that of
P. aeruginosa RR8 over the entire period (Figure 3B). Given
the different endpoints measured by the crystal violet (biofilm
biomass, consisting of both EPS and cells) and the viable
count (biofilm viability) assays, our results indicate that only in
P. aeruginosa does the amount of EPS increase over time during
biofilm formation, as is also confirmed by themucoid appearance
of the biofilm samples observed during macroscopic analysis of
the 96-well plate.
When S. maltophilia RR7 was co-cultured with P. aeruginosa
RR8 in mixed biofilms, its viability was significantly decreased
throughout the period. Conversely, the biofilm viability of
P. aeruginosa RR8 was not affected by the presence of
S. maltophilia RR7.
The CI values of S. maltophilia vs. P. aeruginosa were
always significantly different from the RIR values (p < 0.001)
throughout the 7 days of incubation, which suggests that
P. aeruginosa outcompetes S. maltophilia affecting its growth in
mixed biofilms as well as in planktonic cultures (Figure 3C).
Adhesion to and Biofilm Formation on CFBE41o-
cells
P. aeruginosa RR8 and S. maltophilia RR7 were evaluated,
both alone and in mixed culture, for adhesion to, and biofilm
formation onto, CFBE41o- CF cell monolayer. The results of the
viable count assay are summarized in Figure 4.
When monolayers were separately infected, the adhesiveness
of P. aeruginosa RR8 to CFBE41o- cells was significantly higher
than that of S. maltophilia RR7 (1.3 ± 0.3 × 107 vs. 2.8 ± 0.7 ×
105 CFU/well, respectively; p < 0.01) (Figure 4A). Conversely,
when CFBE41o- cell monolayer was concomitantly challenged
by both strains their degrees of adhesiveness were comparable.
However, the adhesiveness of P. aeruginosa RR8 was significantly
less than that observed in monoculture (1.1 ± 0.7 × 106 vs.
1.3 ± 0.3 × 107 CFU/well, respectively; p < 0.05), unlike
S. maltophilia RR7, whose adhesiveness was not affected by the
presence of P. aeruginosa RR8. The comparative analysis of
the CI and the RIR values showed no statistically significant
difference (Figure 4C), although a comparison of efficiency
values, from single and mixed cultures, showed a significant
decrease for P. aeruginosa RR8 (from 12.9 to 4.9%, respectively;
p < 0.05), whereas a significant increase was found for
S. maltophilia RR7 (from 0.08 to 0.3%, respectively; p <
0.001).
Both S. maltophilia RR7 and P. aeruginosa RR8 showed
comparable biofilm viability when tested in monoculture
(Figure 4B). However, when CFBE41o- cell monolayer was
simultaneously infected by both strains, the concentration of
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FIGURE 2 | Kinetics of adhesion onto polystyrene by S. maltophilia
RR7 and P. aeruginosa RR8, considered both as alone and in
combination. Adhesion was assessed, after 3 h of incubation at 37◦C, both
by crystal violet and viable count assays. (A) Crystal violet assay. S. maltophilia
RR7, and P. aeruginosa RR8 were tested both alone (RR7, RR8), and in mixed
infection (RR7 + RR8), and the results are shown as mean + SD (n = 6).
**p < 0.01, ***p < 0.001, ANOVA + Newman-Keuls post-test. (B) Viable count
assay. S. maltophilia RR7 and P. aeruginosa RR8 strains were tested both
alone (RR7, RR8), and in mixed infection (RR7combi, RR8combi), and the
results are shown as mean + SD (n = 6). No statistically significant differences
were found among groups by ANOVA + Newman-Keuls post-test. (C)
Competitive index (CI; black bars) and Relative Increase Ratio (RIR; gray bars),
calculated from single and dual cultures of S. maltophilia RR7 and
P. aeruginosa RR8. The results are shown as mean ± SD (n = 6). CI vs. RIR,
no statistically significant difference, unpaired t-test.
FIGURE 3 | Kinetics of biofilm formation onto polystyrene by
S. maltophilia RR7 and P. aeruginosa RR8, both considered as alone
and in combination. Biofilm formation was assessed, over 7 days, both by
(A) crystal violet and (B) viable count assays. S. maltophilia RR7 and
P. aeruginosa RR8 were tested both alone (RR7, RR8), and in mixed infection
(RR7 + RR8), and the results are shown as mean + SD (n = 6). *p < 0.05,
**p < 0.01, ***p < 0.001, RR7 vs. RR8; ∧p < 0.05, ∧∧p < 0.01,
∧∧∧p < 0.001, RR7 vs. RR7combi; §p < 0.05, RR8 vs. RR8combi; ANOVA +
Newman-Keuls post-test. (C) Competitive index (CI; black bars) and Relative
Increase Ratio (RIR; gray bars) calculated from single and dual biofilm cultures
of S. maltophilia RR7 and P. aeruginosa RR8. The results are shown as mean
± SD (n = 6). ***p < 0.001, CI vs. RIR, unpaired t-test.
P. aeruginosa RR8 in mixed biofilm was significantly higher than
that of S. maltophilia RR7 (2.2 ± 1.5 × 107 vs. 3.2 ± 2.9 × 105
CFU/well, respectively; p < 0.05), whose concentration was
significantly lower than that observed in monomicrobial biofilm
(2.3± 0.5× 107 CFU/well; p < 0.05) (Figure 4B).
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FIGURE 4 | Adhesion and biofilm formation by S. maltophilia RR7 and
P. aeruginosa RR8 onto CFBE41o- CF bronchial cells. CFBE41o- cell
monolayers were exposed for (A) 3 h (adhesion assay) or (B) 24 h (biofilm
formation assay) to S. maltophilia RR7 and P. aeruginosa RR8 (each at 106
CFU/ml; MOI: 10), tested as alone (RR7, RR8) or in mixed cultures (RR7combi,
RR8combi). *p < 0.05, **p < 0.01, ANOVA + Newman-Keuls post-test. (C) In
mixed cultures, the Competitive Index (CI) and the Relative Increase Ratio (RIR)
were calculated as described in Materials and Methods. The results are shown
as mean + SD (n = 6). **p < 0.01; unpaired t-test.
The comparative analysis of the CI and the RIR values
obtained for biofilm formation assay showed statistically different
values (−2.3 ± 0.4 vs. −0.5 ± 0.4, respectively; p < 0.01)
(Figure 4C). Relative to the biofilm cells/initial inoculum ratio
calculated for each strain, the values obtained from mono- and
mixed cultures were significantly elevated for P. aeruginosa RR8
(from 31.8 to 96.2%, respectively; p < 0.001), while a significant
decrease was observed for S. maltophilia RR7 (from 6.9 to 0.5%,
respectively; p < 0.001).
Taken together, these results suggest the existence of a
reciprocal interference between these two species in the adhesion
step. S. maltophilia RR7 negatively affects P. aeruginosa RR8
adhesiveness, whereas later, during biofilm formation onto
CFBE41o- cells, P. aeruginosa RR8 outcompetes S. maltophilia
RR7, probably by inhibiting its growth.
Exposure to S. maltophilia Culture Supernatant
Significantly Reduces Swimming Motility in
P. aeruginosa
The effect of the presence of one strain, tested as culture
supernatant, on swimming, swarming and twitching motilities of
the other strain was evaluated and the results are summarized in
Figures 5A,B.
The swimming motility exhibited by P. aeruginosa RR8
was significantly reduced by exposure to S. maltophilia RR7
culture supernatant (mean ± SD: 18.6 ± 1.3 vs. 25.8 ±
0.8mm, with or without supernatant, respectively; p < 0.001)
(Figure 5A). No significant variations were observed between
groups for swarming and twitching motilities. P. aeruginosa RR8
supernatant did not affect any of S. maltophiliaRR7motility types
tested (Figure 5B).
S. maltophilia is Less Susceptible than
P. aeruginosa to Tobramycin in Mixed Biofilms
The activity of tobramycin at 128µg/ml against single and mixed
preformed biofilm was assessed by the viable count and the
results are summarized in Figure 5C. Exposure to tobramycin
significantly reduced the viability of both S. maltophilia RR7 and
P. aeruginosa RR8 monomicrobial biofilms (S. maltophilia RR7:
1.1± 0.5× 107 vs. 8.0± 5.0× 105 CFU/well; P. aeruginosa RR8:
2.2 ± 2.5 × 106 vs. 2.2 ± 2.4 × 104 CFU/well; unexposed and
tobramycin-treated biofilms, respectively; p < 0.001). However,
when mixed biofilms were tested, tobramycin resulted to be
effective against P. aeruginosa RR8 only (1.1± 0.9×107 vs. 3.4±
4.7×104 CFU/well; unexposed and tobramycin-treated biofilms,
respectively; p < 0.001).
S. maltophilia Significantly Affects P. aeruginosa
Virulence in Mixed Biofilm
The effect of exposure to S. maltophilia RR7 on the expression
of nine selected virulence genes (rhlR, lasI, aprA, vfr, exoS, toxA,
algD, mexC, mexE) of P. aeruginosa RR8 was assayed, by RT-
PCR, both in mono- and co-cultured biofilms; the results are
summarized in Figure 6. When grown in mixed biofilm with S.
maltophilia RR7, P. aeruginosa RR8 significantly overexpressed
aprA, and algD genes (p < 0.05), codifying for protease and
alginate, respectively, whereas the QS-related rhlR and lasI genes
were down-regulated (p < 0.05). The presence of S. maltophilia
RR7 also caused a considerable increase of eﬄux pump systems-
related mexC and mexE genes, as well as of toxA, codifying for
exotoxin A, expression by P. aeruginosa RR8, although this trend
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FIGURE 5 | (A,B) Effect of culture supernatants on motility. Swimming,
swarming, and twitching motilities of each strain were assessed as previously
described (Pompilio et al., 2008). (A) P. aeruginosa RR8 motility was evaluated
both in the presence and absence of S. maltophilia RR7 culture supernatant
(sup RR7). (B) S. maltophilia RR7 motility was evaluated both in the presence
and absence of P. aeruginosa RR8 culture supernatant (sup RR8). The results
are shown as mean + SD (n = 6). ***p < 0.001, paired-t test. (C) Activity of
tobramycin against preformed biofilms. Monomicrobial and mixed biofilms
were allowed to grow for 24 h, and then they were exposed to tobramycin
128µg/ml (TOB) or CAMHB only (control, CTRL) for further 24 h. Biofilm’s
viability was then assessed by viable count. The results are shown as mean +
SD (n = 6). ***p < 0.001, ANOVA + Newman-Keuls post-test.
resulted not to be statistically significant, probably due to high SD
values.
Discussion
The originality of this study is two-fold. Firstly, it evaluates
the nature of interactions occurring between P. aeruginosa and
S. maltophilia under both planktonic and biofilm growth, and
specifically whether these interactions offer enhanced fitness
compared to single cultures. Secondly, it considers S. maltophilia
and P. aeruginosa strains isolated at the same time from the
same CF patient during a PE episode, whereas previous works
were conducted using strains isolated from different, and non-CF,
patients (Kataoka et al., 2003; Ryan et al., 2008; Varposhti et al.,
2014).
Following examination of the interaction between
S. maltophilia and P. aeruginosa under planktonic growth
conditions, the CI and RIR values suggested that P. aeruginosa
outcompetes S. maltophilia, during both exponential and
stationary growth phases. This microbial antagonism could
be due to competition for both nutrients and space or, more
directly, to an antibacterial effect of one species toward the other
(Harrison, 2007; Hibbing et al., 2010). Our findings from the
agar spot assay in fact clearly showed, for the first time, that
P. aeruginosa exerts antibacterial activity against S. maltophilia.
As suggested by the transwell-based assay results, this effect
is probably not mediated by exoproducts, but requires direct
contact between cells, which suggests that P. aeruginosa, in
order to achieve new niches, might kill S. maltophilia by injecting
specific proteins via the type VI secretion system (Tashiro et al.,
2013).
Despite the increasing interest in the crucial role played by
biofilm in determining CF infections, interspecies interactions in
mixed biofilms are still poorly understood. Using a polystyrene
microtiter assay, the reciprocal interaction between S. maltophilia
and P. aeruginosa was initially evaluated at the adhesion phase,
the first step of biofilm formation. Our findings confirmed
that EPS plays a crucial role during P. aeruginosa adhesion,
and interestingly showed that the presence of S. maltophilia
reduces the amount of EPS, probably secondary to loss or a
reduced synthesis, therefore affecting P. aeruginosa adhesion to
the substratum.
The kinetics of biofilm formation were then monitored
throughout the 7 day-incubation period with daily medium
replacement, in order to simulate a chronic infection. When
both species were cultured alone, we found that in P. aeruginosa,
unlike S. maltophilia, EPS amount increases over time during
biofilm formation. When simultaneously cultured in mixed
biofilms, we observed that S. maltophilia and P. aeruginosa
cannot coexist in a dynamic equilibrium in mixed biofilm:
S. maltophilia will always be outcompeted. The results from
the viable count in fact indicated that the contribution of
S. maltophilia to the biomass of mixed biofilm is negligible,
being at least 100-fold lower than P. aeruginosa concentration.
The comparative evaluation between single and dual specie
biofilms showed that the capacity of P. aeruginosa to form
biofilms is unaffected by the presence of S. maltophilia,
while that of S. maltophilia is significantly reduced in
the presence of P. aeruginosa. The antibacterial activity
exhibited in planktonic cultures by P. aeruginosa is probably
one of the mechanisms that inhibits S. maltophilia biofilm
formation.
In contrast with our findings, Varposhti et al. (2014)
found that S. maltophilia, in mixed cultures, induces
P. aeruginosa biofilm biomass formation on Foley catheter.
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FIGURE 6 | Effect of S. maltophilia RR7 on P. aeruginosa RR8 virulence-related gene expression in mixed biofilm. S. maltophilia RR7 and P. aeruginosa
RR8 were allowed to grow, as mixed biofilm, in a 24-well microtiter polystyrene plate at 37◦C for 24 h (RR8 combi, gray bars). Relative expression of nine selected
P. aeruginosa virulence genes (algD, rhlR, lasI, aprA, exoS, vfr, mexC, mexE, toxA) were then measured by RT-PCR. P. aeruginosa grown alone as biofilm was
considered as control (RR8, black bars). The results are shown as mean + SD (n = 6). *p < 0.05, paired t-test.
The discrepancy could be explained by the fact that strains tested
in combinations by Varposhti et al. were from different patients
with polymicrobial lower respiratory infections. This might be
particularly relevant in the case of CF chronic infections, where
P. aeruginosa undergoes adaptation to the CF lung leading
to patho-adaptative lineages genotypically and phenotypically
different (Huse et al., 2010), which has been observed not only
when comparing isolates from different CF patients, but also
when comparing multiple isolates from the same CF respiratory
specimen (Lee et al., 2005).
The polystyrene microtiter assay is classically used for biofilm
studies due to its ease of use and ability for high-throughput
testing. However, since not all variables can be controlled, the
conditions still differ significantly from those observed during
natural infections and, therefore, the results might be of limited
clinical relevance. The interaction between P. aeruginosa and
S. maltophilia during adhesion and biofilm formation was
therefore also assessed using a CF-derived bronchial epithelial
cell monolayer.
In single infections, P. aeruginosa was more adhesive than
S. maltophilia, which disagrees with the polystyrene microtiter
assay. However, when the cell monolayer was simultaneously
challenged with mixed cultures, the adhesiveness of P. aeruginosa
was significantly reduced relative to monoculture, while that of
S. maltophilia remained unaffected. The results from motility
assays suggested that S. maltophilia might reduce P. aeruginosa
adhesiveness to bronchial cells by affecting its ability to reach the
substratum via swimming motility, probably as a consequence of
flagellar loss or a reduced expression of flagella-associated genes.
In accordance with the polystyrene microtiter assay, the viable
count showed that P. aeruginosa outcompetes S. maltophilia in
mixed biofilms formed onto CF bronchial cells. Accordingly, we
also observed that S. maltophilia can not affect P. aeruginosa
biofilm formation by modulating its swarming or twitching
motility.
Recent studies on the behavior of multispecies communities
have shown that the virulence and the gene expression
of pathogens can be modulated by the presence of other
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bacterial species (Duan et al., 2003). Therefore, we performed a
comparative analysis of transcript levels of several P. aeruginosa
virulence factors both in single- and dual-species biofilms. The
quantitative PCR results suggested that S. maltophilia changes
the physiology and, consequently, the virulence of P. aeruginosa.
Specifically, both aprA and algD operon—codifying for the
frank P. aeruginosa virulence factors alkaline protease and
alginate, respectively—were up-regulated in the presence of
S. maltophilia, whereas the QS-related rhlR and lasI genes
were down-regulated. These differences may be the expression
of a defensive reaction by P. aeruginosa to the presence of
S. maltophilia. Alternatively, since both bacterial species exist
ubiquitously in various environments, including the rhizosphere
of plants (Berg et al., 2005), the lack of significant differences
in the expression of other genes observed in co-culture may be
highly suggestive of their relative acclimatization to each other.
P. aeruginosa causes severe tissue damage by the expression
of the alkaline protease AprA, especially in CF patients where
it has been associated with increased infectivity and virulence,
suggesting a role in processes related to bacterial colonization
and/or exacerbation in the CF lung (Burke et al., 1991; Kim
et al., 2006). Our findings suggested that in mixed infections
S. maltophilia might indirectly facilitate the onset of PEs
in CF patients by inducing increased proteolytic activity in
P. aeruginosa, probably via a Las/RhI independent pathway.
On the other hand, S. maltophilia might also promote
P. aeruginosa adaptation to the airways of CF patients by
favoring phenotypic traits acquired by P. aeruginosa only
during chronic infections, which has the result of promoting
long-term survival in CF lungs. Particularly, we observed in
mixed biofilms the loss of LasR function and overproduction
of alginate. Loss of QS regulation is generally considered a
hallmark of chronic virulence and has been described for several
P. aeruginosa CF isolates (Geisenberger et al., 2000; D’Argenio
et al., 2007). Specifically, loss of LasR function has clinical
implications for disease progression and antibiotic resistance
since it produces an increase in β-lactamase activity, which
augments tolerance to ceftazidime, a widely used β-lactam
antibiotic in CF patients (D’Argenio et al., 2007). In addition,
mucoid strains overproducing alginate have been found to be
dominant in chronic lung infections, and therefore correlated
with a poor prognosis (Yang et al., 2011). Furthermore, by
increasing algD expression S. maltophilia might favor the
protection of P. aeruginosa against oxygen radicals from activated
PMNs (Govan and Deretic, 1996), and improve its ability to form
more robust biofilms (Hoffmann et al., 2005).
Understanding the interspecies interactions is essential, not
only because they can potentially modulate the virulence and the
persistence of pathogens such as P. aeruginosa, but also because it
might lead to the development of new, more effective, therapeutic
strategies. We found that the exposure of a mixed biofilm to
tobramycin reduced the viability of P. aeruginosa but not of
S. maltophilia. It is, therefore, plausible that the S. maltophilia-
induced alginate expression by P. aeruginosamight ensure added
protection both to S. maltophilia against tobramycin, and to
P. aeruginosa against other antimicrobial agents. This might
explain why about 25% of patients do not recover their baseline
lung function after treatment for a PE episode (Sanders et al.,
2010, 2011), therefore suggesting that a suitable CF treatment
should take into consideration the threat of such nosocomial
indirect pathogens as S. maltophilia.
In conclusion, for the first time our findings show that a
reciprocal interference between S. maltophilia and P. aeruginosa
in CF lung is plausible. P. aeruginosa exhibits an aggressive
lifestyle dominating S. maltophilia during competitive planktonic
growth and biofilm development. However, in CF lung
S. maltophilia cannot be considered as simply a “by-stander.” In
fact, growing in a biofilm together with S. maltophilia changes
the physiology of P. aeruginosa and, therefore, modulates its
virulence profile. This might confer some selective “fitness
advantage” to P. aeruginosa under the specific conditions of
chronic infection or, alternatively, cause its hypervirulentation
thus leading to PE.
Our findings, however, need to be confirmed by
in vitro and in vivo investigations focused on other CF
S. maltophilia/P. aeruginosa combinations since, in infections
where both species are present, the outcome over time could be
highly influenced by the phenotype of the strains involved.
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